X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1433) 1433
Publication (189) 189
Book Chapter (27) 27
Book Review (11) 11
Conference Proceeding (10) 10
Streaming Video (4) 4
Magazine Article (3) 3
Web Resource (3) 3
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
eculizumab (1191) 1191
index medicus (845) 845
humans (781) 781
complement (380) 380
female (377) 377
male (336) 336
hematology (305) 305
hemolytic-uremic syndrome (297) 297
antibodies, monoclonal, humanized - therapeutic use (292) 292
complement inhibitor eculizumab (291) 291
urology & nephrology (277) 277
adult (252) 252
thrombotic microangiopathy (252) 252
atypical hemolytic uremic syndrome (242) 242
paroxysmal nocturnal hemoglobinuria (200) 200
transplantation (194) 194
middle aged (173) 173
diagnosis (161) 161
treatment outcome (159) 159
paroxysmal-nocturnal hemoglobinuria (158) 158
pediatrics (158) 158
medicine & public health (148) 148
care and treatment (143) 143
immunology (141) 141
child (137) 137
complement activation (134) 134
activation (132) 132
hemolytic uremic syndrome (131) 131
mutation (129) 129
adolescent (127) 127
medicine, general & internal (126) 126
thrombosis (126) 126
kidney transplantation (125) 125
disease (121) 121
therapy (120) 120
children (118) 118
hemic and lymphatic diseases (118) 118
young adult (118) 118
plasma exchange (115) 115
mutations (114) 114
thrombotic thrombocytopenic purpura (110) 110
anemia (109) 109
hemoglobinuria, paroxysmal - drug therapy (109) 109
hemolysis (109) 109
ahus (108) 108
nephrology (108) 108
management (106) 106
monoclonal antibodies (106) 106
animals (101) 101
alternative pathway (99) 99
natural-history (98) 98
aged (96) 96
abridged index medicus (90) 90
health aspects (90) 90
recurrence (90) 90
pregnancy (89) 89
rituximab (87) 87
patients (86) 86
analysis (84) 84
research (83) 83
pnh (81) 81
membranoproliferative glomerulonephritis (80) 80
oncology (79) 79
risk factors (79) 79
inhibitor eculizumab (77) 77
kidneys (76) 76
urologic and male genital diseases (76) 76
child, preschool (75) 75
atypical hemolytic uremic syndrome - drug therapy (73) 73
immunosuppressive agents - therapeutic use (73) 73
retrospective studies (73) 73
article (72) 72
case report (72) 72
glomerulonephritis (72) 72
thrombocytopenic purpura (71) 71
dense deposit disease (70) 70
hemoglobinuria, paroxysmal - diagnosis (70) 70
antibodies (69) 69
antibodies, monoclonal, humanized (68) 68
antibodies, monoclonal, humanized - administration & dosage (68) 68
infant (67) 67
antibodies, monoclonal - therapeutic use (66) 66
c3 glomerulopathy (66) 66
proteins (65) 65
prognosis (61) 61
renal-transplantation (61) 61
hemoglobinuria, paroxysmal - complications (60) 60
complement inactivating agents - therapeutic use (57) 57
review (57) 57
complement factor h - genetics (56) 56
hus (56) 56
surgery (56) 56
complement system proteins - immunology (55) 55
drug therapy (55) 55
complement activation - drug effects (53) 53
deficiency (53) 53
hemoglobinuria, paroxysmal - therapy (53) 53
impact (53) 53
peripheral vascular disease (53) 53
stem cells (53) 53
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1304) 1304
French (39) 39
German (37) 37
Spanish (33) 33
Russian (17) 17
Japanese (11) 11
Czech (5) 5
Turkish (5) 5
Hungarian (3) 3
Polish (3) 3
Portuguese (3) 3
Italian (2) 2
Dutch (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


RHEUMATOLOGY, ISSN 1462-0324, 07/2016, Volume 55, Issue 7, pp. 1337 - 1340
Journal Article
Journal of Rheumatology, ISSN 0315-162X, 12/2018, Volume 45, Issue 12, pp. 1710 - 1711
Dermatomyositis (DM) is a rare autoimmune disease that belongs to the group of idiopathic inflammatory myopathies (IIM). The usual treatment of DM was based on... 
ECULIZUMAB | POLYMYOSITIS | RHEUMATOLOGY
Journal Article
Kidney International, ISSN 0085-2538, 10/2019, Volume 96, Issue 4, pp. 829 - 833
Journal Article
Journal Article
Seminars in Hematology, ISSN 0037-1963, 07/2018, Volume 55, Issue 3, pp. 124 - 129
Paroxysmal nocturnal hemoglobinuria (PNH) arises from a somatic mutation in the phosphatidylinositol glycan class A, X-linked gene, responsible for a... 
Eculizumab | Paroxysmal Nocturnal Hemoglobinuria | Thrombosis | Aplastic anemia | MANAGEMENT | COMPLEMENT INHIBITOR ECULIZUMAB | INTRAVASCULAR HEMOLYSIS | GENETIC-VARIANTS | PNH | PREGNANCY | RECEIVING ECULIZUMAB | ERYTHROCYTES | DISEASE | HEMATOLOGY | APLASTIC-ANEMIA
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 4, pp. 518 - 525
Abstract We recently observed that dysregulation of the complement system may be involved in the pathogenesis of hematopoietic stem cell... 
Hematology, Oncology and Palliative Medicine | Hematopoietic stem cell transplant | Eculizumab | Thrombotic microangiopathy | Eculizumab pharmacokinetics | CH50 | DIAGNOSIS | LONG-TERM SURVIVORS | COMPLEMENT | HEMOLYTIC-UREMIC SYNDROME | IMMUNOLOGY | TRANSPLANTATION | GLOMERULAR-FILTRATION-RATE | Hematopoietic stem cell | CYSTATIN-C | transplant | Eculizumab pharrnacokinetics | CHRONIC KIDNEY-DISEASE | HYPERTENSION | HEMATOLOGY | CHSO | Hematologic Neoplasms - therapy | Severity of Illness Index | Complement Hemolytic Activity Assay | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Hematologic Neoplasms - mortality | Humans | Child, Preschool | Complement Membrane Attack Complex - antagonists & inhibitors | Thrombotic Microangiopathies - mortality | Transplantation, Autologous | Hematologic Neoplasms - pathology | Transplantation, Homologous | Drug Dosage Calculations | Complement Inactivating Agents - therapeutic use | Hematopoietic Stem Cell Transplantation - adverse effects | Survival Analysis | Hematologic Neoplasms - immunology | Thrombotic Microangiopathies - etiology | Drug Monitoring | Child | Thrombotic Microangiopathies - immunology | Thrombotic Microangiopathies - drug therapy | Hypertension | Enzymes | Mortality | Stem cells | Transplantation | Children | Health aspects | Hematopoietic stem cells
Journal Article
Anaerobe, ISSN 1075-9964, 09/2019, p. 102099
Fusobacterium nucleatum is a common oral commensal bacterium capable of severe invasive infections. We report a case of a diffuse bilateral pneumopathy with F.... 
Journal Article
NEFROLOGIA, ISSN 0211-6995, 09/2015, Volume 35, Issue 5, pp. 421 - 447
Journal Article
Kidney International, ISSN 0085-2538, 09/2019, Volume 96, Issue 3, pp. 761 - 768
Terminal complement inhibition therapy with eculizumab (a humanized monoclonal antibody to C5) has revolutionized the treatment of patients with thrombotic... 
eculizumab | IgG subclasses | thrombotic microangiopathy | ACTIVATION | HEMOLYTIC-UREMIC SYNDROME | COMPLEMENT INHIBITOR ECULIZUMAB | DISEASE | UROLOGY & NEPHROLOGY | OUTCOMES | AHUS
Journal Article
NEFROLOGIA, ISSN 0211-6995, 2013, Volume 33, Issue 1, pp. 27 - 45
Haemolytic uraemic syndrome (HUS) is a clinical entity defined as the triad of nonimmune haemolytic anaemia, thrombocytopenia, and acute renal failure, in... 
COFACTOR PROTEIN CD46 | Thrombotic microangiopathy | LIVER-KIDNEY TRANSPLANTATION | Complement | RENAL-TRANSPLANTATION | THROMBOTIC THROMBOCYTOPENIC PURPURA | FACTOR-I | PROPHYLACTIC ECULIZUMAB | INHIBITOR ECULIZUMAB | GENE | Atypical hemolytic uremic syndrome | Eculizumab | UROLOGY & NEPHROLOGY | MUTATIONS | COMPLEMENT-FACTOR-H
Journal Article
Journal Article
NEFROLOGIA, ISSN 0211-6995, 03/2017, Volume 37, Issue 2, pp. 225 - 227
Journal Article
Turkish Nephrology, Dialysis and Transplantation Journal, ISSN 1300-7718, 2018, Volume 27, Issue 3, pp. 308 - 312
Journal Article
Transplantation, ISSN 0041-1337, 08/2017, Volume 101, Issue 12, pp. 2924 - 2930
BACKGROUNDAtypical hemolytic uremic syndrome (aHUS) is an orphan disease with a high rate of recurrence after kidney transplantation. However, reports of... 
PROPHYLACTIC ECULIZUMAB | SURGERY | ADULT PATIENTS | MANAGEMENT |